{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06554717","recordId":"NCT06554717","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06554717-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct06554717.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct06554717.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2024-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-08-12","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"7f93b741341172798fc50195ef5e30cd1d74a92be4970c114483d91a80ce4f04","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2024-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-08-15","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"87f32760202459f86c20309ac91c2942b1b7fd44fdb63a4e58856b240854d892","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-04-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-04-25","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"1e939aaa81b5e139fe2fb81b98f09dd0b3999597752665983d0312c08e349716","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Oversight","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-05-23","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"c7223ac8f46b7e2b1165555a08c69352b41ebca28d6169515e0a636a36b312bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-07-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-07-28","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"bec91eb5e6a368636be6da671e2b6979b66f7426005c6e4e85776d303a47328e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"8b78805533f5ac233011f78fef2238be27fac2149c889d90cbf10c3158701ab7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2026-05-15","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"32cb089f56934b121547fadc4eac8f12c646df6d3f5a11a39a6c225f515a42ed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ec0a499f9516be35da3f4e25329f2f544d85cf03e5ab78e69208a7bcc81ef44b"}}